Interestingly, our investigation highlighted ANGPT2 overexpression in several tumour types, particularly esophageal carcinoma, which may warrant future studies to evaluate its correlation with patient prognosis, given that ANGPT2 has previously been validated as a consistent biomarker in esophageal squamous cell carcinoma 1. Here, ANGPT2 is linked to neoplasm.